# FDA Inspection 829154 - Biomat USA Inc - April 26, 2013

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e2a755e3-9dba-4d99-9a2e-e2db6f6f1abe
Source feed: FDA_Inspections

> FDA Inspection 829154 for Biomat USA Inc on April 26, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 829154
- Company Name: Biomat USA Inc
- Inspection Date: 2013-04-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1172470 - 2022-05-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/76e0c69c-c2b3-4aa0-9455-3517ecea140e)
- [FDA Inspection 1172470 - 2022-05-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/13ec2d59-c687-4788-a516-6ff080df0332)
- [FDA Inspection 1049693 - 2018-03-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/675c9316-a40b-4488-bea7-c78416a87f53)
- [FDA Inspection 923243 - 2015-04-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b851a7ef-a840-4530-b1c3-283945a4a808)
- [FDA Inspection 717721 - 2011-04-01](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3c2e3066-3ac6-4623-8034-16ab1dfc13e3)

Company: https://www.keypedia.com/companies/biomat-usa-inc/877c950b-c4a0-4152-bf0c-2e031b8dba75

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d